Clin2
NCT06968208Possibly a fitNot yet recruiting

Testing puerarin for obesity treatment

Metabolic DiseasesObesity/Therapy

Part of Hormones & metabolism clinical trials.

This trial tests whether puerarin, a plant-based supplement, is safe and effective for helping people with obesity lose weight. It may also improve related health issues like high blood sugar or cholesterol.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
80 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • Your body mass index (BMI) is 30 or higher.
  • You have not taken any weight-loss, diabetes, or cholesterol medications before.
  • Your weight has stayed stable (not changed by more than 3%) for at least a month.
  • You are willing to stop any weight-control medications, supplements, or herbal products for the trial.
  • You do not have any serious medical conditions like heart disease, liver or kidney problems, or active infections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07279194Recruiting· Phase 3
Study of HDM1005 for weight loss in Chinese adults without diabetes

This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.

Shanghai
NCT07725809Not yet recruiting· Phase 1
Study of a new medicine for adults with overweight or obesity

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Brussels, Bruxelles-capitale, Région de
NCT07731139Not yet recruiting· Phase 1
Testing a new medicine for people with obesity

This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.

Lake Forest, California
NCT07378033Enrolling by invitation
Body fat reduction and weight management study

This study tests a new approach to help with weight loss and body fat reduction. It may be a good fit if you are an adult with a BMI in the overweight to moderately obese range and you are not currently using weight-loss medications.

Bangalore, Karnataka
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07790861Not yet recruiting· Phase 3
Study of an oral weight loss medication in Chinese adults with overweight or obesity

This trial tests an investigational oral medication to help Chinese adults with overweight or obesity, plus related health issues, lose weight. It focuses on improving weight loss and overall health in this group.

Chengdu

Hear when a new Obesity/Therapy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.